140 related articles for article (PubMed ID: 26352490)
21. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
Rabadi MH; Vincent AS
Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of multiple sclerosis in the Serbian district Sumadija.
Toncev G; Miletic Drakulic S; Knezevic Z; Boskovic Matic T; Gavrilovic A; Toncev S; Drulovic J; Pekmezovic T
Neuroepidemiology; 2011; 37(2):102-6. PubMed ID: 21921643
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and incidence of multiple sclerosis in Panama (2000-2005).
Gracia F; Castillo LC; Benzadón A; Larreategui M; Villareal F; Triana E; Arango AC; Lee D; Pascale JM; Gomez E; Armien B
Neuroepidemiology; 2009; 32(4):287-93. PubMed ID: 19246933
[TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis in Brazil: A systematic review.
Vasconcelos CC; Thuler LC; Rodrigues BC; Calmon AB; Alvarenga RM
Clin Neurol Neurosurg; 2016 Dec; 151():24-30. PubMed ID: 27756020
[TBL] [Abstract][Full Text] [Related]
26. [Multiple sclerosis: descriptive study of its clinical forms in 302 cases].
Moreira MA; Felipe E; Mendes MF; Tilbery CP
Arq Neuropsiquiatr; 2000 Jun; 58(2B):460-6. PubMed ID: 10920407
[TBL] [Abstract][Full Text] [Related]
27. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.
Bernitsas E; Bao F; Seraji-Bozorgzad N; Chorostecki J; Santiago C; Tselis A; Caon C; Zak I; Millis S; Khan O
Mult Scler Relat Disord; 2015 Jan; 4(1):47-51. PubMed ID: 25787052
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence and characteristics of multiple sclerosis in the health district of the Marina Alta].
García-Gallego A; Morera-Guitart J
Rev Neurol; 2002 Apr 16-30; 34(8):732-7. PubMed ID: 12080492
[TBL] [Abstract][Full Text] [Related]
29. Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil.
Cardoso E; Fukuda T; Pereira J; Seixas J; Miranda R; Rodrigues B; Saback T; Andrade R; Cardoso G; Martinez R; Avena J; Melo A
Arq Neuropsiquiatr; 2006 Sep; 64(3B):727-30. PubMed ID: 17057875
[TBL] [Abstract][Full Text] [Related]
30. Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Maghzi AH; Etemadifar M; Saadatnia M
Eur J Neurol; 2007 Apr; 14(4):403-7. PubMed ID: 17388988
[TBL] [Abstract][Full Text] [Related]
31. Secondary progressive multiple sclerosis - clinical course and potential predictive factors.
Pokryszko-Dragan A; Gruszka E; Bilińska M; Dubik-Jezierzańska M
Neurol Neurochir Pol; 2008; 42(1):6-11. PubMed ID: 18365957
[TBL] [Abstract][Full Text] [Related]
32. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires.
Fernández O; Baumstarck-Barrau K; Simeoni MC; Auquier P;
Mult Scler; 2011 Oct; 17(10):1238-49. PubMed ID: 21669936
[TBL] [Abstract][Full Text] [Related]
33. A CLINICO-EPIDEMIOLOGICAL STUDY OF MULTIPLE SCLEROSIS IN MOSUL CITY, IRAQ.
Taher Y; Ahmed M; Majdal H
Georgian Med News; 2023; (340-341):47-52. PubMed ID: 37805872
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
Sayao AL; Devonshire V; Tremlett H
Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
[TBL] [Abstract][Full Text] [Related]
35. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
36. [Cavitary lesions in multiple sclerosis: multicenter study on twenty patients].
Corlobé A; Renard D; Goizet C; Berger E; Rumbach L; Robinson A; Dupuy D; Touzé E; Zéphir H; Vermersch P; Brochet B; Edan G; Deburghgraeve V; Créange A; Castelnovo G; Cohen M; Lebrun-Frenay C; Boespflug-Tanguy O; Labauge P
Rev Neurol (Paris); 2013 Dec; 169(12):965-9. PubMed ID: 24139243
[TBL] [Abstract][Full Text] [Related]
37. Late onset multiple sclerosis: concerns in aging patients.
Lotti CBC; Oliveira ASB; Bichuetti DB; Castro I; Oliveira EML
Arq Neuropsiquiatr; 2017 Jul; 75(7):451-456. PubMed ID: 28746432
[TBL] [Abstract][Full Text] [Related]
38. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
Shirani A; Zhao Y; Kingwell E; Rieckmann P; Tremlett H
Mult Scler; 2012 Apr; 18(4):442-50. PubMed ID: 21952097
[TBL] [Abstract][Full Text] [Related]
39. [Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients].
Sekkat Z; Ongagna JC; Collongues N; Fleury M; Blanc F; de Seze J;
Rev Neurol (Paris); 2012 Apr; 168(4):338-43. PubMed ID: 22341991
[TBL] [Abstract][Full Text] [Related]
40. Multiple sclerosis in Hispanics: a study of clinical disease expression.
Amezcua L; Lund BT; Weiner LP; Islam T
Mult Scler; 2011 Aug; 17(8):1010-6. PubMed ID: 21467188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
